Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone

Joseph C. Sardano, Chairman and Chief Executive Officer of Sensus Healthcare

“This is a proud moment for Sensus and one that reflects years of investment in our technology, our customers and our commitment to expanding treatment options for patients”

Joseph C. Sardano, Chairman and Chief Executive Officer of Sensus Healthcare

“We've built a strong foundation of physicians who recognize the value of SRT, and we're now seeing an exciting shift in the commercial environment. With dedicated reimbursement codes in place, greater physician awareness and growing interest from a broader range of dermatology practices, we believe the opportunity to expand adoption has never been stronger.”

Joseph C. Sardano, Chairman and Chief Executive Officer of Sensus Healthcare

“Our vision has always been to make SRT a widely available treatment option for patients who can benefit from a non-invasive approach. Reaching our 1,000th system sale is a significant accomplishment, but what excites me most is the opportunity ahead as we expand our customer base, increase utilization and bring this technology to more physicians and patients”

Joseph C. Sardano, Chairman and Chief Executive Officer of Sensus Healthcare

“Very much looking forward to achieving the next 1,000 units. Thank you to all those customers who continue to show faith in our technology and to the hundreds of thousands of patients who benefit from the noninvasive treatments of SRT”